52-week High Alert: Heavy buying witnessed as this pharmaceutical company announced stellar Q1FY24 results! 52-week High Alert: Heavy buying witnessed as this pharmaceutical company announced stellar Q1FY24 results! On Friday, shares of the company reached at its 52-week high of Rs 658 after surging by more than 3 per cent. Siddharth Mane / Friday, July 21, 2023 / Article rating: 3.7 The company has a ROCE of 29.9 per cent and a ROE of 22.3 per cent.
This pharma company received USDA approval for a generic drug which clocked over Rs 90 crore in sales, do you own it? This pharma company received USDA approval for a generic drug which clocked over Rs 90 crore in sales, do you own it? The company is ranked among the world’s top 100 biopharmaceutical companies and among the world’s top 50 companies in the off-patent sector. Bhavya Rathod / Monday, December 19, 2022 / Article rating: 4.4 Glenmark Pharmaceuticals Ltd is an innovation-driven global pharmaceutical company with a presence across Specialty, Generics and OTC businesses
This pharma company stock went 8 per cent high, do you own it? This pharma company stock went 8 per cent high, do you own it? With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore. Kiran Shroff / Thursday, November 10, 2022 / Article rating: 5.0 This pharma company stock went 8 per cent high, do you own it? With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore.